If you wish to download the documents, please click on the links below:
Current EAMBES Governance and the past Executives of EAMBES.
On 19 June 2015, the Employment, Social Policy, Health and Consumer Affairs Council adopted a partial general approach –excluding the recitals- on the Medical Devices and In Vitro Diagnostic Medical Devices Regulations.
[Read the rest of this article...]
We have decided to extend the deadline for the mail ballot for new members of the EAMBES council until March 13th. Only representatives of the societies can vote and they have received a ballot two weeks ago. So, if you have not voted yet, please take a moment to do so and if you did, many thanks for participating in this democratic process.
Due to health problems our manager Marijke Lensing-Kooiman was, much to her regret, forced to resign from the position of EAMBES manager. EAMBES found a professional manager in Eve Costa - firstname.lastname@example.org - who is willing to take over EAMBES management for a three month period (Jan-Feb-March). She is a charter accountant and she has been managing many SMES for many years. In March it will be decided how to go forward. She is looking forward to meeting you all during the meetings and Scientific Event on March 16 and 17, 2015 in Brussels.
For the course of 2014, health stakeholders in Brussels feared the impact of the proposed General Data Protection Regulation (GDPR) on health research. MEPs seeking to limit the influence of insurance companies and other major players in data imposed strict conditions on the transfer of health data and its very use. This would also apply to medical researchers all over Europe.
The ICT infrastructures and tools that the Human Brain Project (HBP) is developing will catalyse the way neuroscience research will be done in the near future, concluded an independent panel of 19 experts, mandated by the European Commission, after the first annual review meeting of the Human Brain Project (HBP) in January 2015.
On 4 February 2014 the Health committee (ENVI Committee) of the European Parliament published the draft report of the Own-initiative report entitled “Safer healthcare in Europe: improving patient safety and fighting antimicrobial resistance” (2014/2207(INI)).
Following the announcement last year by the President of the European Commission of a ‘European Fund for Strategic Investments’ designed to stimulate the European economy, in January 2015 it materialised that of the €21 billion committed to the stimulus package, € 2.7 billion would be taken from the Horizon 2020 budget (which is around €80 billion) over 5 years.
In the last months, the MedTech and Pharma industry have demonstrated an increasing interest in the ongoing Transatlantic Trade and Investment Partnership (TTIP), the trade agreement that, since July 2013, is being negotiated between the EU and the US.
On the occasion of the last Employment, Social Policy, Health and Consumer Affairs (EPSCO) Council meeting under the Italian Presidency, on 1 December 2014, and following the launch by the Commission last May of a public consultation on the review of the Europe 2020, Ministers exchanged views on the significant contribution that investments in health systems can make to the goals of the EU's growth strategy.
On 18 November 2014, EU “Guidelines on ePrescriptions dataset for electronic exchange under Cross-Border Directive 2011/24/EU” were published. Developed by the eHealth Network set up by the Cross-Border Healthcare Directive, these guidelines are non-binding and apply to prescriptions for medicinal products only.